Sudden death and use of stimulant medications in youths

American Journal of Psychiatry

Volumn 166, Issue 9, 2009, Pages 992-1001

  Gould, Madelyn S ^a   Walsh, B Timothy ^b   Munfakh, Jimmie Lou ^b   Kleinman, Marjorie ^b   Duan, Naihua ^b   Olfson, Mark ^b   Greenhill, Laurence ^b   Cooper, Thomas ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE; CANNABINOID DERIVATIVE; CLONIDINE; DEXAMPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE; NORTRIPTYLINE; PSYCHOSTIMULANT AGENT; RITALINIC ACID; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DEATH CERTIFICATE; DRUG BLOOD LEVEL; DRUG EXPOSURE; FEMALE; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; SUDDEN DEATH; TRAFFIC ACCIDENT; UNITED STATES; VITAL STATISTICS;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CORONERS AND MEDICAL EXAMINERS; DEATH CERTIFICATES; DEATH, SUDDEN; DEXTROAMPHETAMINE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHAMPHETAMINE; METHYLPHENIDATE; RISK FACTORS; UNITED STATES;

EID: 69949090591     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09040472     Document Type: Article

References (40)

1. Trugman JM: Cerebral arteritis and oral methylphenidate. Lancet 1988; 1:584-585
2. George AK, Kunwar AR, Awasthi A: Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. J Child Adolesc Psychopharmacol 2005; 15:693-695 (Pubitemid 41434373)
3. Gandhi PJ, Ezeala GU, Luyen TT, Tu TC, Tran MT: Myocardial infarction in an adolescent taking Adderall. Am J Health Syst Pharm 2005; 62:1494-1497
4. Daly MW, Custer G, McLeay PD: Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram. Pharmacotherapy 2008; 28:1408-1412
5. Gelperin K: Cardiovascular risk with drug treatments of ADHD: feasibility of available study methods in children and adults. http://www.fda.gov/ohrms/ dockets/AC/06/briefing/2006-4210B-Index.htm, 2006 (accessed Sept 16, 2008)
6. Samuels JA, Franco K, Wan F, Sorof JM: Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 2006; 21:92-95 (Pubitemid 43040200)
7. Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A: Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 2007; 120:1494-1501 (Pubitemid 350223669)
8. Towbin K: Paying attention to stimulants: height, weight, and cardiovascular monitoring in clinical practice. J Am Acad Child Adolesc Psychiatry 2008; 47:977-980
9. Wilens TE, Prince JB, Spencer TJ, Biederman J: Stimulants and sudden death: what is a physician to do? Pediatrics 2006; 118:1215-1219
10. U.S. Department of Health and Human Services: Proceedings of the Pediatric Advisory Committee Meeting, March 22, 2006
11. Vetter VL, Elial J, Erickson C, Berger S, Blum N, Uzark K, Webb CL: Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 2008; 117:2407-2423 (Pubitemid 351653546)
12. Perrin JM, Friedman RA, Knilans TK: Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 2008; 122:451-453
13. Berger S, Kugler JD, Thomas JA, Friedberg DZ: Sudden cardiac death in children and adolescents: introduction and overview. Pediatr Clin North Am 2004; 51:1201-1209 (Pubitemid 39149778)
14. Liberthson RR: Sudden death from cardiac causes in children and young adults. N Engl J Med 1996; 334:1039-1044 (Pubitemid 26124453)
15. Riddle MA, Geller B, Ryan N: Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32:792-797 (Pubitemid 23187778)
16. Swanson J, Gupta S, Guinta D, Flynn D, Agler D, Lerner M, Williams L, Shoulson I, Wigal S: Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 1999; 66:295-305 (Pubitemid 29451762)
17. Hunkeler E, Fireman F, Lee J, Diamond R, Hamilton J, He CX, Dea R, Nowell WB, Hargreaves WA: Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003. J Child Adolesc Psychopharmacol 2005; 15:26-37
18. Bromberg BI, Lindsay BD, Cain ME, Cox JL: Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1996; 27:690-695
19. Strauss D, Cable W, Shavelle R: Causes of excess mortality in cerebral palsy. Dev Med Child Neurol 1999; 41:580-585 (Pubitemid 29425583)
20. Yang Q, Rasmussen SA, Friedman JM: Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359:1019-1025
21. Donner EJ, Smith CR, Snead OC 3rd: Sudden unexplained death in children with epilepsy. Neurology 2001; 57:430-434
22. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, Shah AK, Mankad VN; Investigators of the Cooperative Study of Sickle Cell Disease: Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003; 123:359-365
23. Solomon CG, Manson JE: Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997; 66:1044S-1050S
24. Plaza V, Serrano J, Picado C, Sanchis J; High Risk Asthma Research Group: Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002; 19:846-852
25. Neumaerker KJ: Mortality and sudden death in anorexia nervosa. Int J Eat Disord 1997; 21:205-212
26. Zuvekas SH, Vitiello B, Norquist GS: Recent trends in stimulant medication use among US children. Am J Psychiatry 2006; 163:579-585 (Pubitemid 44464565)
27. Schlesselman J: Case Control Studies. New York, Oxford Press, 1982
28. Olfson M, Gameroff MJ, Marcus SC, Jensen PS: National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2003; 160:1071-1077 (Pubitemid 41070965)
29. Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003; 157:17-25 (Pubitemid 36343413)
30. Strom BL (Eds.): Pharmacoepidemiology, 3rd Edition. Chichester, UK, John Wiley & Sons, 2000
31. Matthews JN, Altman DG: Interaction 2: compare effect sizes not p values (statistics notes). BMJ 1996; 313:808
32. Elia J: Cardiovascular monitoring of children with ADHD, in Proceedings of the 55th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Washington, DC, AACAP, 2008
33. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC: Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001; 285:60-66 (Pubitemid 32042717)
34. Gothelf D, Gruber R, Presburger G, Dotan I, Brand-Gothelf A, Burg M, Inbar D, Steinberg T, Frisch A, Apter A, Weizman A: Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. J Clin Psychiatry 2003; 64:1163-1169
35. Kirshbom PM, Flynn TB, Clancy RR, Ittenbach RF, Hartman DM, Paridon SM, Wernovsky G, Spray TL, Gaynor JW: Late neurodevelopmental outcome after repair of total anomalous pulmonary venous connection. J Thoracic Cardiovascular Surgery 2005; 129:1091-1097 (Pubitemid 40631431)
36. Food and Drug Administration: Adderall and Adderall XR (amphetamine). www.fda.gov/cder/drug/InfoSheets/HCP/Adderall-HCPSheet.pdf (accessed Jan 2008)
37. Birmaher B, Greenhill LL, Cooper TB, Fried J, Maminski B: Sustained release methylphenidate: pharmacokinetic studies in ADHD males. J Am Acad Child Adolesc Psychiatry 1989; 28:768-772 (Pubitemid 19239931)
38. Modi NB, Wang B, Noveck RJ, Gupta SK: Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system. J Clin Pharmacol 2000; 40:1141-1149
39. Wolraich ML, Doffing MA: Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs 2004; 18:243-250 (Pubitemid 38393434)
40. Schteinschnaider A, Plaghos LL, Garbugino S, Riveros D, Lazarowski A, Intruvini S, Massaro M: Cerebral arteritis following methylphenidate use. J Child Neurol 2000; 15:265-267 (Pubitemid 30331445)